INTERVIEW | Will Supreme Court Hear Abortion Pill Case? Plaintiffs’ Attorney Weighs In

On Good Friday, a federal judge in Texas handed down a potentially historic abortion ruling.

The case at hand revolves around the Food and Drug Administration’s approval of the abortion pill mifepristone. In 2000, the FDA approved the use of mifepristone to be used along with the drug misoprostol to terminate a pregnancy. But some medical experts have argued the FDA's approval was rushed and unlawful.

In 2022, a group of pro-life medical professionals and an organization represented by Alliance Defending Freedom, a Christian legal organization, filed a lawsuit against the FDA arguing that it had improperly approved the abortion pill, and federal Judge Matthew Kacsmaryk for the Northern District of Texas agreed.

“The Court does not second-guess FDA’s decision-making lightly,” Kacsmaryk wrote in his ruling. “But here, FDA acquiesced on its legitimate safety concerns—in violation of its statutory duty—based on plainly unsound reasoning and studies that did not support its conclusions.”

Denise Harle, Alliance Defending Freedom senior counsel, joins the show today to discuss what the ruling means and the likelihood of the case ultimately rising to the Supreme Court. Harle also breaks down a ruling the same day by a judge in Washington state in favor of continued access to the abortion pill.

Enjoy the show.

Follow the links below to learn more about the case:

https://www.dailysignal.com/2023/04/11/best-part-of-federal-judges-ruling-against-abortion-pill-comes-down-to-two-words/

https://adflegal.org/

Hosted on Acast. See acast.com/privacy for more information.